HIV-1 genotyping and virtual phenotyping

0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Drug resistance testing is recommended for the management of patients with HIV-1 infection. Celera ViroSeq™ HIV-1 Genotyping System is the most widely used genotypic HIV drug resistance testing. The assay produces 1,302 nucleotide sequences comprising codons 1-99 of the protease gene and 1-335 of the reverse transcriptase gene. Genotyping result is linked to an interpretive algorithm, for example, Virco® TYPE HIV-1 to generate drug resistance profile.

Cite

CITATION STYLE

APA

Xu, F., & Dong, J. (2012). HIV-1 genotyping and virtual phenotyping. In Modern Clinical Molecular Techniques (pp. 97–121). Springer New York. https://doi.org/10.1007/978-1-4614-2170-2_8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free